403 related articles for article (PubMed ID: 17464246)
1. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
4. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
5. CpG island methylator phenotypes in aging and cancer.
Toyota M; Issa JP
Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
[TBL] [Abstract][Full Text] [Related]
6. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
Matsubara N
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of genetic and epigenetic alterations in cancer.
Toyota M; Suzuki H; Yamamoto E; Yamano H; Imai K; Shinomura Y
Epigenomics; 2009 Dec; 1(2):291-9. PubMed ID: 22122704
[TBL] [Abstract][Full Text] [Related]
8. The CpG island methylator phenotype is not associated with a personal or family history of cancer.
Ward RL; Williams R; Law M; Hawkins NJ
Cancer Res; 2004 Oct; 64(20):7618-21. PubMed ID: 15492290
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
10. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
12. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
13. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
Messick CA; Church J; Casey G; Kalady MF
Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
[TBL] [Abstract][Full Text] [Related]
14. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
15. The potential role of epigenetic therapy in multiple myeloma.
Smith EM; Boyd K; Davies FE
Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
[TBL] [Abstract][Full Text] [Related]
16. Methylation and colorectal cancer.
Jubb AM; Bell SM; Quirke P
J Pathol; 2001 Sep; 195(1):111-34. PubMed ID: 11568897
[TBL] [Abstract][Full Text] [Related]
17. The role of DNA hypermethylation in human neoplasia.
Toyota M; Issa JP
Electrophoresis; 2000 Jan; 21(2):329-33. PubMed ID: 10675010
[TBL] [Abstract][Full Text] [Related]
18. The clinical application of targeting cancer through histone acetylation and hypomethylation.
Gilbert J; Gore SD; Herman JG; Carducci MA
Clin Cancer Res; 2004 Jul; 10(14):4589-96. PubMed ID: 15269129
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
[TBL] [Abstract][Full Text] [Related]
20. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]